TITLE: Whole genetic approach in Early Genetic Identification of Obesity (WEGIO) DESIGN: Multicenter epidemiological study STUDY POPULATION: Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS) NUMBER OF PARTICIPANTS: 1000 for initial genetic sequencing and app. 40 for the follow-up documentation COORDINATING INVESTIGATOR: Prof. Dr. Arndt Rolfs
TITLE: Whole genetic approach in Early Genetic Identification of Obesity (WEGIO) DESIGN: Multicenter epidemiological study STUDY POPULATION: Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS) NUMBER OF PARTICIPANTS: 1000 for initial genetic sequencing and app. 40 for the follow-up documentation COORDINATING INVESTIGATOR: Prof. Dr. Arndt Rolfs PARTICIPATING COUNTRY: Germany TREATMENT: Not applicable PRIMARY OBJECTIVE: To investigate the prevalence of BBS in an at-risk population SECONDARY OBJECTIVES: * To explore genotype-phenotype correlation * To assess genotypes distribution in Germany and compare to other countries * To identify new genes/variants * To investigate clinical characteristics in individuals diagnosed with BBS DURATION OF RECRUITMENT: 32 months - total 24 months the recruitment of 1000 subjects 27 months follow up visits 32 months close out of sites INCLUSION CRITERIA: * Informed consent is obtained from the participant/parent/legal guardian * The participant is 2 years of age or older For a participant between 2 and 18 years of age: * The participant has and had a body weight more than 97th percentile before the age of 6 * The participant has one or more of the following symptoms: rod/cone dystrophy, renal abnormalities, ataxia, syndactyly, polydactyly, brachydactyly, hyperphagia, cognitive impairment, speech delay, hypogonadism For a participant who is 18 years of age or older: * The participant has BMI ≥ 30 kg/m2 * The participant had a body weight more than 97th percentile before the age of 6 years * The participant has rod/cone dystrophy * The participant is 2 or more years of age, is clinically diagnosed with Bardet-Biedl-Syndrome (BBS) or is a sibling of an individual diagnosed with BBS via the WEGIO study
Study Type
OBSERVATIONAL
Enrollment
1,000
blood collection
Universitätsklinikum Aachen (RWTH)
Aachen, Germany
KJF Klinik Josefinum
Augsburg, Germany
Universitätsklinikum Augsburg - Klinik für Kinder- und Jugendmedizin
Augsburg, Germany
Universitätsklinikum Freiburg
Bad Krozingen, Germany
Klinikum Bielefeld Mitte
Bielefeld, Germany
Universitätsklinikum Bonn
BBS prevalence
To investigate the prevalence of BBS in patients suspected to a genetic obesity
Time frame: 2 years
Phenotypic and genetic characterization
To understand the genotype-phenotype correlation; to assess genotypes distribution in Germany and compare to other countries; to identify new genes/variants; to investigate clinical characteristics in individuals diagnosed with BBS
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bonn, Germany
Praxis für Endokrinologie Dr. Daniel Pfaff
Bückeburg, Germany
Cellitinnen-Krankenkaus St. Franziskus
Cologne, Germany
Universitätsmedizin Essen
Essen, Germany
Klinikum Frankfurt (Oder)
Frankfurt (Oder), Germany
...and 27 more locations